BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24916387)

  • 1. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
    Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
    EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
    Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
    RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
    Fossat N; Tam PP
    RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
    Wolfe AD; Arnold DB; Chen XS
    J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
    Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
    J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.
    Chester A; Somasekaram A; Tzimina M; Jarmuz A; Gisbourne J; O'Keefe R; Scott J; Navaratnam N
    EMBO J; 2003 Aug; 22(15):3971-82. PubMed ID: 12881431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.
    Shivalingappa PKM; Sharma V; Shiras A; Bapat SA
    Mol Cell Biochem; 2021 Dec; 476(12):4493-4505. PubMed ID: 34499322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
    Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
    RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs.
    Rosenberg BR; Hamilton CE; Mwangi MM; Dewell S; Papavasiliou FN
    Nat Struct Mol Biol; 2011 Feb; 18(2):230-6. PubMed ID: 21258325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
    Jarmuz A; Chester A; Bayliss J; Gisbourne J; Dunham I; Scott J; Navaratnam N
    Genomics; 2002 Mar; 79(3):285-96. PubMed ID: 11863358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.
    Maris C; Masse J; Chester A; Navaratnam N; Allain FH
    RNA; 2005 Feb; 11(2):173-86. PubMed ID: 15659357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.
    Blanc V; Xie Y; Luo J; Kennedy S; Davidson NO
    J Lipid Res; 2012 Dec; 53(12):2643-55. PubMed ID: 22993231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.
    Severi F; Conticello SG
    RNA Biol; 2015; 12(4):389-97. PubMed ID: 25806564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.
    Soleymanjahi S; Blanc V; Davidson N
    RNA; 2021 Jun; 27(8):876-90. PubMed ID: 34083494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-to-U RNA Editing: From Computational Detection to Experimental Validation.
    Lerner T; Kluesner M; Tasakis RN; Moriarity BS; Papavasiliou FN; Pecori R
    Methods Mol Biol; 2021; 2181():51-67. PubMed ID: 32729074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
    J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live-Cell Quantification of APOBEC1-Mediated RNA Editing: A Comparison of RNA Editing Assays.
    Chieca M; Torrini S; Conticello SG
    Methods Mol Biol; 2021; 2181():69-81. PubMed ID: 32729075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
    Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
    J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.